Syquant Capital Sas

Name: SYQUANT CAPITAL SAS 13F holdings, Q3 2025
Creator: SYQUANT CAPITAL SAS
Published: 2025-10-28

Q2 2026Q1 2026Q4 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024

In its 13F for Q3 2025 (holdings as of September 30, 2025, filed October 28, 2025), Syquant Capital Sas reported 16 stock positions worth $346.5 million. Its top holding was Verona Pharma (VRNA) at 37.2% of the portfolio, followed by Kellanova (K, 35.8%) and 89BIO (ETNB, 11.0%). Compared with Q2 2025, it opened 13 new positions, sold out of 10 and added to 1. The biggest buy was a new position in Verona Pharma (VRNA) and the biggest sale an exit from Blueprint Medicines (BPMC).

Most Recent 13F: Q2 2026
Location: PARIS, I0
CIK: 0001766392
Portfolio Value: $346.5M (Q3 2025)
SEC Filing: 0001766392-25-000007 ↗ filed Oct 28, 2025

Holdings Value

Holdings 16 stocks · $346.5M


VRNA Verona Pharma Ltd.	37.21%	1,208,312	$128.9M	New
K Kellanova	35.82%	1,513,343	$124.1M	Add +32.3%
ETNB 89BIO Inc.	11.00%	2,593,694	$38.1M	New
IPG Interpublic Group of Cos Inc.	6.88%	854,279	$23.8M	New
INFA Informatica Inc. Class A	3.86%	537,775	$13.4M	New
CEPF Cantor Equity Partners Class A	1.47%	500,000	$5.1M	New
WNS WNS Holdings Ltd. filed as WNS HLDGS LTD	1.07%	48,659	$3.7M	New
CRH CRH PLC	0.82%	23,820	$2.9M	New
MBVIU M3-Brigade Acquisition Vi Co.	0.58%	200,000	$2.0M	New
AEXA American Exceptionalism Class A	0.39%	125,000	$1.4M	New
PACHU Pioneer Acquisition I Corp.	0.32%	110,000	$1.1M	No change
MRUS Merus NV	0.32%	11,691	$1.1M	New
WENNU Wen Acquisition Corp.	0.08%	25,000	$261K	No change
BLZRU Trailblazer Acquisition Corp.	0.07%	25,000	$256K	New
BCSS.U Bain Capital GSS Investment	0.06%	20,000	$202K	New
ONCHU 1RT Acquisition Corp.	0.03%	10,000	$105K	New

Other holdings (1): bonds, preferreds, convertibles and warrants · $2.0M (not counted above)

Security	Class	Shares / Principal	Value	Change
AIRBNB INC (ABNB 0 03/15/26)	NOTE 3/1 · principal	2,000,000	$2.0M	No change

Total filed on the 13F, all lines: $348.4M.

Portfolio Sells Q2 2025 → Q3 2025


BPMC Blueprint Medicines Corp.	Sold out	0.00%	−34.46
ESGR Enstar Group Ltd.	Sold out	0.00%	−8.06
WBA Walgreens Boots Alliance Inc.	Sold out	0.00%	−4.92
TGI Triumph Group Inc.	Sold out	0.00%	−4.88
JNPR Juniper Networks Inc.	Sold out	0.00%	−4.03
SWTX Springworks Therapeutics Inc.	Sold out	0.00%	−3.87
SKX Skechers USA Inc. Class A	Sold out	0.00%	−3.87
DNB Dun & Bradstreet Holdings Inc.	Sold out	0.00%	−3.79
APP AppLovin Corp. Class A	Sold out	0.00%	−0.84
CON Concentra Group Holdings Par	Sold out	0.00%	−0.47

Portfolio Buys Q2 2025 → Q3 2025


VRNA Verona Pharma Ltd.	New	37.21%	+37.21
ETNB 89BIO Inc.	New	11.00%	+11.00
IPG Interpublic Group of Cos Inc.	New	6.88%	+6.88
K Kellanova	Add +32.3%	35.82%	+5.47
INFA Informatica Inc. Class A	New	3.86%	+3.86
CEPF Cantor Equity Partners Class A	New	1.47%	+1.47
WNS WNS Holdings Ltd.	New	1.07%	+1.07
CRH CRH PLC	New	0.82%	+0.82
MBVIU M3-Brigade Acquisition Vi Co.	New	0.58%	+0.58
AEXA American Exceptionalism Class A	New	0.39%	+0.39
MRUS Merus NV	New	0.32%	+0.32
BLZRU Trailblazer Acquisition Corp.	New	0.07%	+0.07
BCSS.U Bain Capital GSS Investment	New	0.06%	+0.06
ONCHU 1RT Acquisition Corp.	New	0.03%	+0.03

All Filings

Quarter	Positions	13F Reported Value	Top Holdings
Q2 2026	37	$447.1M	EA, GTLS, WBD, CCO, DBRG
Q1 2026	40	$640.3M	GTLS, EA, HOLX, WBD, SEE
Q4 2025	36	$815.2M	DAY, BABA, LLY, GTLS, INTU
Q3 2025	16	$346.5M	VRNA, K, ETNB, IPG, INFA
Q2 2025Amended	13	$299.7M	BPMC, K, ESGR, WBA, TGI
Q1 2025	14	$141.0M	K, ITCI, ESGR, BECN, DESP
Q4 2024	6	$70.5M	K, HCP, SMAR, ESGR, CON
Q3 2024	5	$27.1M	HES, SRCL, AY, PRFT, LOGI
Q2 2024	5	$9.9M	HOLI, HIBB, PRFT, LOGI, TRMD
Q1 2024	6	$63.5M	TCN, PXD, HOLI, X, M